Incorporating molecular testing into the care of pediatric patients with thyroid lesions may help optimize management of these patients, according to investigators from Texas Children’s Hospital and the Baylor College of Medicine, in Houston.
In their study, published in Pediatric and Developmental Pathology (2016;19[2]:94-100, PMID: 26366474), the investigators tested 27 thyroid carcinomas from patients aged 10 to 19 years for molecular alterations common in adult thyroid